Phase II trial of vinorelbine in 120-hours continuous infusion in metastatic breast cancer refractory to anthracyclines

被引：0
|
作者：
Jara, C
Alonso, C
Fernandez, A
GomezAldaravi, L
Arroyo, M
Bosch, C
Tres, A
Gonzalez, M
机构：
[1] HOSP LA PAZ,MADRID,SPAIN
[2] HOSP CLIN,ZARAGOZA,SPAIN
[3] GEN HOSP,SECC ONCOL MED,ALBACETE,SPAIN
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [21] A PHASE II TRIAL OF ORAL VINORELBINE AND CAPECITABINE IN ANTHRACYCLINE PRETREATED PATIENTS WITH METASTATIC BREAST CANCER
    Finek, J.
    Holubec, L.
    Svoboda, T.
    Sefrhansova, L.
    Pavlikova, I.
    Votavova, M.
    Sediva, M.
    Filip, S.
    Kozevnikova, R.
    Kormunda, S.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4023 - 4023
  • [22] Pegylated liposomal doxorubicin and vinorelbine in metastatic breast cancer: Final results of a phase II trial
    Elsaid, A. A.
    Awad, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial
    Campisi, C
    Fabi, A
    Papaldo, P
    Tomao, S
    Massidda, B
    Zappala, A
    Ionta, MT
    Cognetti, F
    ANNALS OF ONCOLOGY, 1998, 9 (05) : 565 - 567
  • [24] VINCRISTINE BY CONTINUOUS INFUSION IN REFRACTORY BREAST-CANCER - A PHASE-II STUDY
    HOPKINS, JO
    JACKSON, DV
    WHITE, DR
    MUSS, HB
    COOPER, MR
    STUART, JJ
    SPURR, CL
    WELLS, HB
    RICHARDS, F
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (05): : 529 - 532
  • [25] Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Pateras, H
    Efremidis, AP
    ANNALS OF ONCOLOGY, 2000, 11 (09) : 1155 - 1160
  • [26] Phase II study of vinorelbine (NVB) and UFT in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
    Anton, A
    Puertolas, T
    Ramos, M
    Barnadas, A
    Florian, J
    Grande, R
    Ribelles, N
    Lomas, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 64S - 64S
  • [27] Phase I trial of vinorelbine and sorafenib in metastatic breast cancer (MBC)
    Luu, T. H.
    Frankel, P. H.
    Chung, C. T.
    Mortimer, J. E.
    Hurria, A.
    McNamra, M.
    Koehler, S.
    Somlo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
    Lee, Yu Rim
    Huh, Seok Jae
    Lee, Dong Hyun
    Yoon, Hyun Hwa
    Seol, Young-Mi
    Choi, Young-Jin
    Kwon, Kyung A.
    Lee, Suee
    Oh, Sung Yong
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    Kwon, Hyuk-Chan
    JOURNAL OF BREAST CANCER, 2011, 14 (02) : 140 - 146
  • [29] Phase II Study of Vinorelbine Plus Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines and Taxanes
    Kwon, H.
    Oh, S. Y.
    Kim, S. H.
    Lee, S.
    Lee, J. H.
    Kim, H. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S353 - S353
  • [30] Paclitaxel plus vinorelbine in metastatic breast cancer patients with contraindications to receive anthracyclines: Preliminary results of a phase II study.
    Carbonero, IG
    Martin, M
    Casado, A
    Lluch, A
    Segura, PP
    de Paz, L
    Garcia-Conde, J
    Diaz-Rubio, E
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S4 - S4
12345